文献速递乳腺外科

治疗性乳房成形术的国际多中心前瞻性队列研究:现状与短期结局

Current practice and short-term outcomes of therapeutic mammaplasty in the international TeaM multicentre prospective cohort study.
PubMed 文献 · Br J Surg · 2018-08-22

该国际多中心前瞻性队列研究纳入50个中心880例接受治疗性乳房成形术的患者(共899例手术),主要适应证为避免标准保乳术后的不良美容效果或避免乳房切除术。

核心结论

  • 治疗性乳房成形术是乳房切除术或标准保乳手术的安全有效替代方案。

研究设计与样本

  • 国际多中心前瞻性队列研究,纳入2016年9月1日至2017年6月30日期间在50个中心连续接受治疗性乳房成形术的患者880例,共899例手术。

临床怎么用

  • 对于需扩大保乳范围或避免乳房切除术的患者,治疗性乳房成形术可作为安全有效的选择。

局限性

  • 需进一步研究该技术对生活质量的影响并确立成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Therapeutic mammaplasty, which combines breast reduction and mastopexy techniques with tumour excision, may extend the boundaries of breast-conserving surgery and improve outcomes for patients, but current practice is unknown and high-quality outcome data are lacking. This prospective multicentre cohort study aimed to explore the practice and short-term outcomes of the technique. METHODS: Consecutive patients undergoing therapeutic mammaplasty at participating centres between 1 September 2016 and 30 June 2017 were recruited to the study. Demographic, preoperative, operative, oncological and complication data were collected. The primary outcome was unplanned reoperation for complications within 30 days of surgery. Secondary outcomes included re-excision rates and time to adjuvant therapy. RESULTS: Overall, 880 patients underwent 899 therapeutic mammaplasty procedures at 50 centres. The most common indications were avoidance of poor cosmetic outcomes associated with standard breast-conserving surgery (702 procedures, 78·1 per cent) or avoidance of mastectomy (379, 42·2 per cent). Wise-pattern skin incisions were the most common (429 of 899, 47·7 per cent), but a range of incisions and nipple-areola pedicles were used. Immediate contralateral symmetrization was performed in one-third of cases (284 of 880, 32·3 per cent). In total, 205 patients (23·3 per cent) developed a complication, but only 25 (2·8 per cent) required reoperation. Median postoperative lesion size was 24·5 (i.q.r. 16-38) mm. Incomplete excision was seen in 132 procedures (14·7 per cent), but completion mastectomy was required for only 51 lesions (5·7 per cent). Median time to adjuvant therapy was 54 (i.q.r. 42-66) days. CONCLUSION: Therapeutic mammaplasty is a safe and effective alternative to mastectomy or standard breast-conserving surgery. Further work is required to explore the impact of the technique on quality of life, and to establish cost-effectiveness.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. O'Connell RL, Baker E, Trickey A, et al. Current practice and short-term outcomes of therapeutic mammaplasty in the international TeaM multicentre prospective cohort study. Br J Surg. 2018. PMID: 30132807. doi:10.1002/bjs.10959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。